Bruce Philip Pritchard

Bruce Philip Pritchard currently works at Liminal BioSciences, Inc., as Chief Executive Officer from 2020, Being Digital Ltd., as Non-Executive Director, Porton Biopharma Ltd., as Non-Executive Director, Fairhaven Pharmaceuticals, Inc., as Director, and Scottish Global Health Foundation, as Non-Executive Trustee from 2013.
Mr. Pritchard also formerly worked at Grifols Canada Plasma Resources, Inc., as Chief Executive Officer & Director, CV Therapeutics, Inc., as Senior Director from 2004 to 2006, Ardana Plc, as Finance Director from 2003 to 2004, Astrea Bioseparations Ltd., as Director, Imanova Ltd., as Non-Executive Director from 2012 to 2017, Liminal BioSciences Ltd., as Director, The Institute of Chartered Accountants of Scotland, as Member from 2009 to 2015, ProMetic BioSciences Ltd., as Chief Financial Officer, and The Institute of Directors (United Kingdom), as Member-Examiners Board from 2011 to 2016.
Mr. Pritchard received his undergraduate degree in 1993 from Heriot-Watt University.